ibrutinib venetoclax treatment for mantle cell lymphoma | constantine tam, md, mbbs | ash 2023
Published 6 months ago • 139 plays • Length 2:46Download video MP4
Download video MP3
Similar videos
-
2:00
alpine trial: zanubrutinib vs ibrutinib in treating #cll | constantine tam, md, mbbs | ash 2023
-
1:56
dr. tam on the combination of ibrutinib plus venetoclax in mantle cell lymphoma
-
1:01
next steps for the use of ibrutinib and venetoclax for the treatment of lymphoma
-
3:18
sympatico: safety and efficacy of ibrutinib plus venetoclax for r/r mcl
-
1:52
sympatico: primary analysis results of ibrutinib plus venetoclax for patients with r/r mcl
-
3:10
assoc. prof. constantine tam: ibrutinib venetoclax in r/r mcl - icml 2017
-
1:08
dr. tam on the toxicities of ibrutinib plus venetoclax in mcl
-
2:04
captivate: ibrutinib/venetoclax delivers high rates of umrd in cll
-
1:08
dr. tam on the toxicity of ibrutinib plus venetoclax in mcl
-
2:00
preliminary results of the aim trial of ibrutinib and venetoclax in mantle cell lymphoma
-
1:02
dr. tam on zanubrutinib vs ibrutinib research in mantle cell lymphoma
-
2:00
ibrutinib in mantle cell lymphoma - an update
-
5:36
ash 2019 interview - a/prof constantine tam and deborah sims - cll & mantle cell lymphoma
-
1:30
final results of the aim study of ibrutinib and venetoclax in mantle cell lymphoma
-
1:21
ibrutinib, rituximab and venetoclax in the treatment of patients with newly diagnosed mcl
-
0:26
acalabrutinib plus venetoclax and rituximab in the treatment of mcl
-
3:00
the shine study: adding ibrutinib to br - blood cancers video library
-
0:36
transplantation in ctcl